Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
Authors
Keywords
oncolytic immunotherapy, CAR-T cells, mesenchymal stromal cells, oncolytic adenovirus, helper dependent adenovirus, systemic delivery, HER.2, lung cancer, solid tumor
Journal
MOLECULAR THERAPY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-10
DOI
10.1016/j.ymthe.2021.02.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
- (2020) David Ruano et al. MOLECULAR THERAPY
- Oncolytic Adenovirus Armed with BiTE, Cytokine, and Checkpoint Inhibitor Enables CAR T Cells to Control the Growth of Heterogeneous Tumors
- (2020) Caroline E. Porter et al. MOLECULAR THERAPY
- Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma
- (2020) Lidia Franco-Luzón et al. Oncotarget
- Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses
- (2020) Agata Hadryś et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
- (2020) Alireza Labani-Motlagh et al. Frontiers in Immunology
- Modeling the Efficacy of Oncolytic Adenoviruses In Vitro and In Vivo: Current and Future Perspectives
- (2020) Mary K. McKenna et al. Cancers
- Engineered off-the-shelf therapeutic T cells resist host immune rejection
- (2020) Feiyan Mo et al. NATURE BIOTECHNOLOGY
- Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
- (2020) Meenakshi Hegde et al. Nature Communications
- Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
- (2019) Myoung Woo Lee et al. LEUKEMIA
- Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
- (2019) Mohamed-Reda Benmebarek et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma
- (2019) A-Rum Yoon et al. CANCER RESEARCH
- Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
- (2019) Tahir Muhammad et al. Stem Cell Research & Therapy
- Correction for Yang et al., “Granzyme B Is an Essential Mediator in CD8+ T Cell Killing of Theileria parva-Infected Cells”
- (2019) Jie Yang et al. INFECTION AND IMMUNITY
- Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile
- (2019) Rosa De Groot et al. OncoImmunology
- Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
- (2019) Laura Lorenzo-Sanz et al. Cancer Microenvironment
- Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?
- (2018) Jessica Hoarau-Véchot et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A deep conical agarose microwell array for adhesion independent three-dimensional cell culture and dynamic volume measurement
- (2018) Andreas R. Thomsen et al. LAB ON A CHIP
- Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
- (2018) Shashi Gujar et al. TRENDS IN IMMUNOLOGY
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
- (2018) Marco B. Schaaf et al. Cell Death & Disease
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive
- (2018) Alessandro Poggi et al. Frontiers in Immunology
- CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
- (2018) Sonia Guedan et al. Frontiers in Immunology
- Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer
- (2017) Amanda Rosewell Shaw et al. MOLECULAR THERAPY
- Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models
- (2017) Chengying Xie et al. Stem Cells Translational Medicine
- Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer
- (2017) Faroogh Marofi et al. Frontiers in Immunology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response
- (2017) Qiong Xue et al. Journal for ImmunoTherapy of Cancer
- CCL11, a novel mediator of inflammatory bone resorption
- (2017) Elin Kindstedt et al. Scientific Reports
- 3D modeling of human cancer: A PEG-fibrin hydrogel system to study the role of tumor microenvironment and recapitulate the in vivo effect of oncolytic adenovirus
- (2016) Francesca Del Bufalo et al. BIOMATERIALS
- Darwinian Dynamics of Intratumoral Heterogeneity: Not Solely Random Mutations but Also Variable Environmental Selection Forces
- (2016) M. C. Lloyd et al. CANCER RESEARCH
- Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
- (2016) Johannes Leibacher et al. Stem Cell Research & Therapy
- Exposure of Human CD4 T Cells to IL-12 Results in Enhanced TCR-Induced Cytokine Production, Altered TCR Signaling, and Increased Oxidative Metabolism
- (2016) Aldo Vacaflores et al. PLoS One
- A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies
- (2015) M. Mamonkin et al. BLOOD
- The Antitumor Efficacy of IL2/IL21-Cultured Polyfunctional Neu-Specific T Cells Is TNF /IL17 Dependent
- (2015) V. Phan-Lai et al. CLINICAL CANCER RESEARCH
- Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1–derived oncolytic immunotherapy
- (2015) Kevin J Harrington et al. Expert Review of Anticancer Therapy
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers
- (2015) Valentina Hoyos et al. MOLECULAR THERAPY
- The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy
- (2015) Jun Zhang et al. Stem Cell Research & Therapy
- Individual Motile CD4 + T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells
- (2015) Ivan Liadi et al. Cancer Immunology Research
- Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity
- (2014) M Ando et al. CANCER GENE THERAPY
- Eosinophils and Cancer
- (2014) B. P. Davis et al. Cancer Immunology Research
- Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy
- (2014) Lisa Farzad et al. Molecular Therapy-Oncolytics
- Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
- (2011) Alan Melcher et al. MOLECULAR THERAPY
- Secretion of MIP-1β and MIP-1α by CD8+ T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage
- (2010) Kevin O. Saunders et al. CELLULAR IMMUNOLOGY
- Concise Review: Dissecting a Discrepancy in the Literature: Do Mesenchymal Stem Cells Support or Suppress Tumor Growth?
- (2010) Ann H. Klopp et al. STEM CELLS
- Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive
- (2010) Natalie A. Hutnick et al. VACCINE
- The Interleukin-8 Pathway in Cancer
- (2008) D. J.J. Waugh et al. CLINICAL CANCER RESEARCH
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass Effect
- (2008) Uwe M. Fischer et al. STEM CELLS AND DEVELOPMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More